Health Care

Verastem, Inc. (NASDAQ:VSTM) stock is trading higher on Wednesday as the company announced positive updated results from its RAMP 205 trial, which evaluates the efficacy of its drug combination in treating metastatic pancreatic cancer. The trial demonstrated an 86% overall survival rate at six...

Elicio Therapeutics Inc. (NASDAQ:ELTX) stock is up on Wednesday as the company reported promising clinical observations regarding its ELI-002 7P treatment. Durable Responses And T-Cell Activity Highlight Potential Benefit The cancer immunotherapy company announced that three patients who received...

While Leidos Holdings Inc (NYSE:LDOS) has a strong defense portfolio well aligned with the U.S. Department of Defense's priorities, the impact is offset by intensifying pressure across the "once blooming" health care portfolio, according BofA Securities. • Why are LDOS shares at support? The...

Ocular Therapeutix, Inc. (NASDAQ:OCUL) stock is trading higher on Wednesday as the company prepares for its Investor Day, where it will detail its plans for submitting a New Drug Application (NDA) for AXPAXLI. The stock’s decline comes amid a mixed market backdrop, with S&P 500 futures...

uniQure N.V. (NASDAQ:QURE) stock is up during Wednesday’s premarket session as the company announced plans for a Biologics License Application (BLA) submission for AMT-130, a gene therapy treatment for Huntington’s disease. FDA Opens Accelerated Approval Path This news comes following a...

The Trump administration on Tuesday sued New York state officials and Public Partnerships LLC, accusing them of facilitating fraud in a $10 billion Medicaid home-care program serving disabled patients, according to a U.S. Department of Justice release. The lawsuit, filed in the U.S. District Court...

Outlook Therapeutics Inc. (NASDAQ:OTLK) shares are rising in Wednesday premarket trading after the company announced the FDA accepted its resubmitted Biologics License Application (BLA) for ONS-5010/LYTENAVA. The FDA acknowledged receipt of the application on Tuesday. If approved, ONS-5010/LYTENAVA...

The U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet on Thursday, June 18, to discuss approval of Moderna Inc.’s (NASDAQ:MRNA) experimental mRNA-based flu vaccine. FDA Advisory Committee To Review Moderna Flu...

Centene Corp. (NYSE:CNC) will offer buyouts to most employees as the health insurer seeks to reduce costs following a significant decline in membership across its health plans. The U.S. insurer launched a voluntary separation program that will allow eligible employees to apply for buyouts. However...

On Monday, the Centers for Medicare & Medicaid Services (CMS) proposed removing the coverage with evidence development (CED) requirement for Transcatheter Aortic Valve Replacement (TAVR) in patients with symptomatic severe aortic stenosis. William Blair on Tuesday wrote, "…this is a...

Edgewise Therapeutics Inc. (NASDAQ:EWTX) on Tuesday released topline results from the 12-week Part D cohort of its Phase 2 CIRRUS-HCM trial. Patients received doses ranging from 25 mg to 150 mg. EDG-7500 demonstrated clinically meaningful improvements in patients with both obstructive and...

Moderna Inc. (NASDAQ:MRNA) announced changes to its operating model and leadership structure. The biotechnology company is preparing for potential new product launches and advancing a broad pipeline. The company said the changes will support both its near-term and long-term objectives. On May 1,...

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) shares are trading higher during Tuesday’s session as the company has announced plans to separate its Minimal Residual Disease (MRD) and Immune Medicine businesses. The decision announced on Monday comes after both segments have shown...

HCW Biologics Inc. (NASDAQ:HCWB) stock fell during Tuesday’s session. The company announced preliminary results from its Phase 1 trial for HCW9302, an IL-2-based treatment for alopecia areata. All participants in the second-dose cohort showed clinical responses after a single dose of the...

iRhythm Holdings Inc. (NASDAQ:IRTC) disclosed a cybersecurity incident involving unauthorized access to data stored on certain third-party-hosted business applications, after a threat actor claimed to have obtained sensitive company and patient information and demanded payment to prevent its public...